A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States
- 1 September 2004
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 66 (3), 1239-1247
- https://doi.org/10.1111/j.1523-1755.2004.00877.x
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Calcium, Phosphate, and Parathyroid Hormone Levels in Combination and as a Function of Dialysis Duration Predict MortalityJournal of the American Society of Nephrology, 2004
- Health Economic Evaluations: The Special Case of End-Stage Renal Disease TreatmentMedical Decision Making, 2002
- Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patientsAmerican Journal of Kidney Diseases, 2002
- Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observationAmerican Journal of Kidney Diseases, 2001
- Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in managementAmerican Journal of Kidney Diseases, 2000
- Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing DialysisThe New England Journal of Medicine, 2000
- C-reactive protein as an outcome predictor for maintenance hemodialysis patientsKidney International, 1998
- Economic evaluation of end stage renal disease treatmentHealth Policy, 1998
- Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national studyAmerican Journal of Kidney Diseases, 1998
- Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patientsAmerican Journal of Kidney Diseases, 1996